John Nuss, CHIEF SCIENTIFIC OFFICER at Ventyx Biosciences, Inc. (VTYX), sold 21,119 shares at $2.36 ($50K) on 2024-12-27, disclosed to the SEC on 2024-12-30.
Open-market sale of $50k VTYX by CHIEF SCIENTIFIC OFFICER. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| VTYX | SELL | 2024-12-19 | $30K | — | Filing → |
| VTYX | SELL | 2024-04-03 | $9K | — | Filing → |
| VTYX | SELL | 2023-12-21 | $37K | — | Filing → |